Victrex plc (VCT) - Total Assets

Latest as of September 2025: GBX566.90 Million GBX ≈ $68.98K USD

Based on the latest financial reports, Victrex plc (VCT) holds total assets worth GBX566.90 Million GBX (≈ $68.98K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Victrex plc shareholders equity for net asset value and shareholders' equity analysis.

Victrex plc - Total Assets Trend (1994–2025)

This chart illustrates how Victrex plc's total assets have evolved over time, based on quarterly financial data.

Victrex plc - Asset Composition Analysis

Current Asset Composition (September 2025)

Victrex plc's total assets of GBX566.90 Million consist of 32.7% current assets and 67.3% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 4.3%
Accounts Receivable GBX49.20 Million 8.7%
Inventory GBX109.70 Million 19.4%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX2.10 Million 0.4%
Goodwill GBX14.30 Million 2.5%

Asset Composition Trend (1994–2025)

This chart illustrates how Victrex plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Victrex plc stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Victrex plc's current assets represent 32.7% of total assets in 2025, a decrease from 59.4% in 1994.
  • Cash Position: Cash and equivalents constituted 4.3% of total assets in 2025, down from 20.6% in 1994.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1994.
  • Asset Diversification: The largest asset category is inventory at 19.4% of total assets.

Victrex plc Competitors by Total Assets

Key competitors of Victrex plc based on total assets are shown below.

Company Country Total Assets
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
Germany €13.95 Billion
Peric Special Gases Co. Ltd. A
SHG:688146
China CN¥6.57 Billion
Akzo Nobel NV
AS:AKZA
Netherlands €13.95 Billion
Jiangsu Nata Opto Electr Material
SHE:300346
China CN¥6.27 Billion
Jiangsu Pacific Quartz Co Ltd
SHG:603688
China CN¥6.11 Billion
Qingdao Gon Technology Co Ltd
SHE:002768
China CN¥19.79 Billion
Shandong Head Co Ltd
SHE:002810
China CN¥4.07 Billion
Boai NKY Pharmaceuticals Ltd
SHE:300109
China CN¥4.24 Billion

Victrex plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.01 4.39 5.55
Quick Ratio 1.23 1.88 2.96
Cash Ratio 0.00 0.00 0.00
Working Capital GBX123.80 Million GBX155.50 Million GBX172.90 Million

Victrex plc - Advanced Valuation Insights

This section examines the relationship between Victrex plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.41
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -4.2%
Total Assets GBX566.90 Million
Market Capitalization $6.53 Million USD

Valuation Analysis

Below Book Valuation: The market values Victrex plc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Victrex plc's assets decreased by 4.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Victrex plc (1994–2025)

The table below shows the annual total assets of Victrex plc from 1994 to 2025.

Year Total Assets Change
2025-09-30 GBX566.90 Million
≈ $68.98K
-4.24%
2024-09-30 GBX592.00 Million
≈ $72.03K
-5.52%
2023-09-30 GBX626.60 Million
≈ $76.24K
-2.34%
2022-09-30 GBX641.60 Million
≈ $78.06K
+4.27%
2021-09-30 GBX615.30 Million
≈ $74.86K
+11.97%
2020-09-30 GBX549.50 Million
≈ $66.86K
+2.48%
2019-09-30 GBX536.20 Million
≈ $65.24K
-4.90%
2018-09-30 GBX563.80 Million
≈ $68.60K
+4.78%
2017-09-30 GBX538.10 Million
≈ $65.47K
+13.84%
2016-09-30 GBX472.70 Million
≈ $57.51K
+10.83%
2015-09-30 GBX426.50 Million
≈ $51.89K
+2.45%
2014-09-30 GBX416.30 Million
≈ $50.65K
+13.25%
2013-09-30 GBX367.60 Million
≈ $44.73K
+12.86%
2012-09-30 GBX325.70 Million
≈ $39.63K
+13.17%
2011-09-30 GBX287.80 Million
≈ $35.02K
+3.15%
2010-09-30 GBX279.00 Million
≈ $33.95K
+26.27%
2009-09-30 GBX220.95 Million
≈ $26.88K
-1.08%
2008-09-30 GBX223.36 Million
≈ $27.18K
+15.46%
2007-09-30 GBX193.45 Million
≈ $23.54K
+16.18%
2006-09-30 GBX166.50 Million
≈ $20.26K
+29.61%
2005-09-30 GBX128.46 Million
≈ $15.63K
+25.05%
2004-09-30 GBX102.73 Million
≈ $12.50K
+24.42%
2003-09-30 GBX82.56 Million
≈ $10.05K
+5.44%
2002-09-30 GBX78.30 Million
≈ $9.53K
+22.44%
2001-09-30 GBX63.95 Million
≈ $7.78K
+3.83%
2000-09-30 GBX61.60 Million
≈ $7.49K
+37.78%
1999-09-30 GBX44.71 Million
≈ $5.44K
+14.46%
1998-09-30 GBX39.06 Million
≈ $4.75K
+22.94%
1997-09-30 GBX31.77 Million
≈ $3.87K
+20.55%
1996-09-30 GBX26.36 Million
≈ $3.21K
+16.05%
1995-09-30 GBX22.71 Million
≈ $2.76K
-5.53%
1994-09-30 GBX24.04 Million
≈ $2.93K
--

About Victrex plc

LSE:VCT UK Specialty Chemicals
Market Cap
$6.53 Million
GBX53.64 Billion GBX
Market Cap Rank
#27839 Global
#416 in UK
Share Price
GBX616.00
Change (1 day)
+2.16%
52-Week Range
GBX539.00 - GBX905.00
All Time High
GBX2680.46
About

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainabl… Read more